Migraines associated with lower risk of breast cancerNovember 06, 2008SEATTLE - Women who suffer from migraines may take at least some comfort in a recent, first-of-its-kind study that suggests a history of such headaches is associated with a significantly lower risk of breast cancer. Christopher I. Li, M.D., Ph.D., and colleagues at Fred Hutchinson Cancer Research Center report these findings in the November issue of Cancer Epidemiology, Biomarkers and Prevention. "We found that, overall, women who had a history of migraines had a 30 percent lower risk of breast cancer compared to women who did not have a history of such headaches," said Li, a breast-cancer epidemiologist and associate member of the Hutchinson Center's Public Health Sciences Division. In particular, migraine history appeared to reduce the risk of the most common subtypes of breast cancer: those that are estrogen-receptor and/or progesterone-receptor positive. Such tumors have estrogen and/or progesterone receptors, or docking sites, on the surface of their cells, which makes them more responsive to hormone-blocking drugs than tumors that lack such receptors.
The biological mechanism behind the association between migraines and breast cancer is not fully known, but Li and colleagues suspect that it has to do with fluctuations in levels of circulating hormones. "Migraines seem to have a hormonal component in that they occur more frequently in women than in men, and some of their known triggers are associated with hormones," Li said. "For example, women who take oral contraceptives - three weeks of active pills and one week of inactive pills to trigger menstruation - tend to suffer more migraines during their hormone-free week," he said. Conversely, pregnancy - a high-estrogen state - is associated with a significant decrease in migraines. "By the third trimester of pregnancy, 80 percent of migraine sufferers do not have these episodes," he said. Estrogen is known to stimulate the growth of hormonally sensitive breast cancer. While this study represents the first of its kind to look at a potential connection between migraines and breast cancer, Li and colleagues have data from two other studies that in preliminary analyses appear to confirm these findings, he said. "While these results need to be interpreted with caution, they point to a possible new factor that may be related to breast-cancer risk. This gives us a new avenue to explore the biology behind risk reduction. Hopefully this could help stimulate other ideas and extend what we know about the biology of the disease." For the study, the researchers combined data from two population-based, case-control studies of 3,412 Seattle-area postmenopausal women, 1,938 of whom had been diagnosed with breast cancer and 1,474 of whom had no history of breast cancer, who served as a comparison group. Information on migraine history was based on self-report and was limited to migraines that had been diagnosed by a physician or other health professional. Fred Hutchinson Cancer Research Center Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Quantum Physics Eating Disorder MicroRNA Endangered Species Liver Cells Hepatitis B Hypertension Color Vision Melatonin Explosives Hodgkin Lymphoma Child Care Hormone Therapy Ovarian Cancer Sleep-disordered Breathing Physical Activity Adhesive Video Game Gamma Ray Mental Health Glutamate Motor Neurons Broadband Radiation Exposure Chronic Disease
See More: Science News Tags | |||||||||||||||||||||
|
Related Breast Cancer Current Events and Breast Cancer News Articles Newly appreciated membrane estrogen receptor important therapeutic target for breast cancer New research at Rhode Island Hospital has uncovered the biological effects of a novel membrane estrogen receptor, a finding that has potential implications for hormonal therapy for breast cancer. Study shows PET can measure effectiveness of novel breast cancer treatment A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended. New MRI technique could mean fewer breast biopsies in high-risk women A University of Wisconsin-Madison biomedical engineer and colleagues have developed a method that, applied in MRI scans of the breast, could spare some women with increased breast cancer risk the pain and stress of having to endure a biopsy of a questionable lump or lesion. Researchers pinpoint a new enemy for tumor-suppressor p53 Researchers at The University of Texas M. D. Anderson Cancer Center have identified a protein that marks the tumor suppressor p53 for destruction, providing a potential new avenue for restoring p53 in cancer cells. What should a teenage girl do if she finds a lump in her breast? If a lump is found in the breast of an adolescent girl, she often will undergo an excisional biopsy. Study challenges routine use of MRI scans to evaluate breast cancer Reviewing the records of 577 breast cancer patients, Fox Chase Cancer Center researchers found that women with newly diagnosed breast cancer who receive a breast MRI are more likely to receive a mastectomy after their diagnosis and may face delays in starting treatment. A new take on growth factor signaling in tamoxifen resistance Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study, published in the open access journal BMC Medical Genomics, suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling. Study finds cancer is the second most frequent cause of death in individuals with schizophrenia People with schizophrenia die from cancer four times as often as people in the general population. Green tea may affect prostate cancer progression According to results of a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research, men with prostate cancer who consumed the active compounds in green tea demonstrated a significant reduction in serum markers predictive of prostate cancer progression. Novel light-sensitive compounds show promise for cancer therapy Chemists at the University of California, Santa Cruz, have developed novel compounds that show promise for photodynamic cancer therapy, which uses light-activated drugs to kill tumor cells. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||